HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Muhammad Wasif Saif Selected Research

Colorectal Neoplasms (Colorectal Cancer)

1/2020Treatment options in BRAF-mutant metastatic colorectal cancer.
1/2020Alternative Treatment Options in Patients with Colorectal Cancer Who Encounter Fluoropyrimidine-Induced Cardiotoxicity.
1/2019Open-label study to evaluate trifluridine/tipiracil safety, tolerability and pharmacokinetics in patients with advanced solid tumours and hepatic impairment.
10/2016Phase 1 study of the anti-vascular endothelial growth factor receptor 3 monoclonal antibody LY3022856/IMC-3C5 in patients with advanced and refractory solid tumors and advanced colorectal cancer.
9/2015Management of regorafenib-related toxicities: a review.
1/2015Safety and Efficacy of Combined Yttrium 90 Resin Radioembolization with Aflibercept and FOLFIRI in a Patient with Metastatic Colorectal Cancer.
1/2015Bevacizumab in combination with fluoropyrimidine-irinotecan- or fluoropyrimidine-oxaliplatin-based chemotherapy for first-line and maintenance treatment of metastatic colorectal cancer.
12/2014Incidence and management of ZIv-aflibercept related toxicities in colorectal cancer.
11/2014Safety and efficacy of radiofrequency ablation with aflibercept and FOLFIRI in a patient with metastatic colorectal cancer.
11/2014Hypersensitivity reactions associated with oxaliplatin and their clinical management.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Muhammad Wasif Saif Research Topics

Disease

163Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 07/2005
152Neoplasms (Cancer)
04/2024 - 07/2005
41Adenocarcinoma
11/2023 - 07/2006
41Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 01/2004
34Gastrointestinal Neoplasms (Gastrointestinal Cancer)
09/2021 - 03/2008
27Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2020 - 11/2010
17Neoplasm Metastasis (Metastasis)
01/2021 - 07/2007
15Exanthema (Rash)
01/2020 - 09/2006
13Diarrhea
01/2020 - 03/2007
11Nausea
04/2024 - 07/2007
11Hypersensitivity (Allergy)
11/2014 - 07/2007
11Primitive Neuroectodermal Tumors (PNET)
03/2014 - 03/2011
10Pain (Aches)
04/2024 - 12/2009
10Colonic Neoplasms (Colon Cancer)
01/2020 - 09/2007
7Neutropenia
03/2021 - 08/2010
7Breast Neoplasms (Breast Cancer)
11/2020 - 12/2006
7Carcinoid Tumor (Carcinoid)
01/2019 - 01/2011
7Vomiting
07/2017 - 03/2007
7Hemorrhage
12/2015 - 03/2001
6Weight Loss (Weight Reduction)
01/2020 - 07/2007
6Cardiotoxicity
01/2020 - 01/2008
6Hand-Foot Syndrome
09/2014 - 09/2006
6Carcinogenesis
07/2014 - 06/2008
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2024 - 01/2009
5Carcinoma (Carcinomatosis)
11/2019 - 11/2010
5Dihydropyrimidine Dehydrogenase Deficiency
01/2017 - 09/2006
4Pancreatitis
04/2024 - 09/2001
4Fever (Fevers)
01/2020 - 01/2009
4Thrombocytopenia (Thrombopenia)
11/2019 - 10/2009
4Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
09/2019 - 04/2012
4Disease Progression
01/2018 - 07/2005
4Fatigue
01/2018 - 03/2010
4Thrombosis (Thrombus)
07/2014 - 03/2010
3Hematologic Neoplasms (Hematological Malignancy)
04/2024 - 07/2013
3Abdominal Pain (Pain, Abdominal)
04/2024 - 07/2007
3Type 2 Diabetes Mellitus (MODY)
09/2021 - 02/2016
3Anemia
09/2021 - 09/2006
3Infections
03/2021 - 01/2006
3Sarcoma (Soft Tissue Sarcoma)
11/2020 - 09/2007
3Acromegaly
01/2020 - 07/2011
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
09/2019 - 10/2016

Drug/Important Bio-Agent (IBA)

85GemcitabineFDA Link
03/2021 - 07/2005
44Capecitabine (Xeloda)FDA Link
03/2021 - 07/2005
40Fluorouracil (Carac)FDA LinkGeneric
01/2020 - 07/2006
29Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2019 - 01/2004
22Biomarkers (Surrogate Marker)IBA
05/2018 - 05/2008
19Erlotinib Hydrochloride (CP 358,774)FDA Link
03/2016 - 01/2007
18Bevacizumab (Avastin)FDA Link
01/2015 - 03/2006
17Irinotecan (Camptosar)FDA LinkGeneric
10/2017 - 07/2007
14Leucovorin (Folinic Acid)FDA Link
11/2019 - 09/2006
13Monoclonal AntibodiesIBA
10/2016 - 01/2007
12PlatinumIBA
01/2021 - 11/2007
12Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2020 - 03/2010
12Cetuximab (Erbitux)FDA Link
01/2020 - 11/2006
12ErbB Receptors (EGF Receptor)IBA
07/2013 - 01/2007
11Sunitinib (Sutent)FDA Link
01/2020 - 03/2010
11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016 - 03/2006
8Octreotide (Sandostatin)FDA LinkGeneric
08/2019 - 11/2010
8Hormones (Hormone)IBA
09/2018 - 01/2005
8EnzymesIBA
01/2018 - 09/2006
8folfirinoxIBA
07/2017 - 07/2007
8Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
06/2010 - 09/2006
7Metformin (Glucophage)FDA LinkGeneric
09/2021 - 07/2011
7Proteins (Proteins, Gene)FDA Link
07/2014 - 09/2006
6Mitomycin (Mitomycin-C)FDA LinkGeneric
01/2021 - 07/2005
6AntigensIBA
01/2020 - 04/2007
6130-nm albumin-bound paclitaxelIBA
01/2020 - 07/2013
6EverolimusFDA Link
07/2013 - 03/2010
6MucinsIBA
03/2013 - 04/2007
6Tyrosine Kinase InhibitorsIBA
07/2011 - 01/2007
6Panitumumab (Vectibix)FDA Link
12/2010 - 01/2007
5VaccinesIBA
06/2020 - 09/2007
5Imatinib Mesylate (Gleevec)FDA Link
09/2019 - 04/2012
5Cisplatin (Platino)FDA LinkGeneric
01/2017 - 07/2005
5afliberceptIBA
01/2015 - 11/2013
5Antineoplastic Agents (Antineoplastics)IBA
09/2012 - 06/2008
4Insulin (Novolin)FDA Link
04/2024 - 09/2010
4pegfilgrastim (Neulasta)FDA Link
03/2021 - 01/2009
4Anti-Bacterial Agents (Antibiotics)IBA
03/2021 - 01/2009
4Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2021 - 03/2011
4lanreotide (Somatuline)FDA Link
08/2019 - 01/2016
4Cytotoxins (Cytolysins)IBA
01/2017 - 12/2006
4Carboplatin (JM8)FDA LinkGeneric
01/2017 - 01/2010
4Tumor Biomarkers (Tumor Markers)IBA
03/2016 - 03/2008
4Temozolomide (Temodar)FDA LinkGeneric
01/2016 - 03/2010
4Docetaxel (Taxotere)FDA Link
03/2014 - 07/2007
4ProdrugsIBA
10/2009 - 11/2008
4Thymidine PhosphorylaseIBA
09/2009 - 07/2007
3Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2021 - 03/2011
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2020 - 03/2011

Therapy/Procedure

112Therapeutics
09/2021 - 01/2004
99Drug Therapy (Chemotherapy)
09/2021 - 07/2006
24Radiotherapy
01/2021 - 07/2005
7Adjuvant Chemotherapy
08/2020 - 07/2008
7Immunotherapy
01/2020 - 03/2009
7Neoadjuvant Therapy
07/2014 - 05/2007
6Palliative Care (Palliative Therapy)
10/2017 - 03/2007
5Precision Medicine
01/2017 - 07/2009
5Salvage Therapy
03/2016 - 05/2008
4Biological Therapy
01/2016 - 01/2007